Alto Neuroscience
Clinical trials sponsored by Alto Neuroscience, explained in plain language.
-
New hope for tough depression: ALTO-207 trial launches
Symptom relief Recruiting nowThis study tests an experimental drug called ALTO-207 in adults whose depression has not improved with at least two prior treatments. About 178 participants will receive either the drug or a placebo for several weeks. The main goal is to see if ALTO-207 reduces depression symptom…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Brain patch trial aims to sharpen thinking in schizophrenia
Symptom relief Recruiting nowThis study tests whether a skin patch called ALTO-101 can improve cognitive function in people with schizophrenia who have thinking problems. About 82 participants will receive either the active patch or a placebo, then switch after a period. The main goal is to see changes in br…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC